Clinical Trials Browser

Phase 2 × rubitecan × Gastrointestinal × Clear all

NCT00005874 2013-12-04

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Phase 2 Completed

GastrointestinalSarcoma

Leiomyosarcoma, Sarcoma, Gastrointestinal Stromal Tumors

NCT00005876 2013-12-04

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00005877 2013-12-04

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms